Business UpdateJun 15, 2026, 03:41 PM
Global Innovative Platforms Updates Business, Adds Key Partners
AI Summary
Global Innovative Platforms Inc. issued a shareholder update detailing significant progress across its business. The company submitted its 15c2-11 application to FINRA, commenced an 8-month heartworm study, and initiated development of four new breath signatures for intestinal parasites. GIPL also expanded its Board of Directors and Strategic Advisory Board, secured a new collaboration with Big Dog Ranch Rescue for sample collection, and won a pitch competition at the Plug and Play incubator program. The company reported sufficient capital through year-end 2026 and extended a revenue-producing collaboration.
Key Highlights
- FINRA 15c2-11 application submitted on June 12, 2026, by sponsoring broker-dealer.
- Commenced an 8-month heartworm treatment study on April 1, 2026, and initiated 4 new breath signatures.
- Acquired its third VetBreath Dx analyzer unit, significantly accelerating sample collection capacity.
- Revenue-producing collaboration extended through July, generating $15,000-$18,000 per month.
- Revenue for the six months ended March 31, 2026, totaled $136,500.
- Formally seated Board of Directors on April 1, 2026, with four new members.
- Partnered with Big Dog Ranch Rescue for high-volume animal sample collection.
- Won the pitch competition at the Plug and Play incubator program.
Price Impact
More from GIPL